These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20148381)

  • 21. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A heroin prescription trial: case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods.
    Lasnier B; Brochu S; Boyd N; Fischer B
    Int J Drug Policy; 2010 Jan; 21(1):28-35. PubMed ID: 19447025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic prescription of heroin to drug addicts].
    Cancrini L
    Recenti Prog Med; 2001 Jan; 92(1):1-5. PubMed ID: 11260964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.
    Oviedo-Joekes E; March JC; Romero M; Perea-Milla E
    Drug Alcohol Rev; 2010 Jan; 29(1):75-80. PubMed ID: 20078686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Length of first admission and treatment outcome in patients with unipolar depression.
    Lauber C; Lay B; Rössler W
    J Affect Disord; 2006 Jul; 93(1-3):43-51. PubMed ID: 16530846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heroin-assisted treatment of opioid addicts in Switzerland from 1994-2001--utilisation and characteristics of admissions and discharges].
    Gschwend P; Rehm J; Eschmann S; Uchtenhagen A
    Gesundheitswesen; 2003 Feb; 65(2):75-80. PubMed ID: 12632315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of substance-dependent youth following 12-step treatment.
    Winters KC; Stinchfield R; Latimer WW; Lee S
    J Subst Abuse Treat; 2007 Jul; 33(1):61-9. PubMed ID: 17588490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of patient retention in a newly established methadone maintenance treatment programme.
    del Rio M; Mino A; Perneger TV
    Addiction; 1997 Oct; 92(10):1353-60. PubMed ID: 9489052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance abuse treatment for mothers: treatment outcomes and the impact of length of stay.
    Conners NA; Grant A; Crone CC; Whiteside-Mansell L
    J Subst Abuse Treat; 2006 Dec; 31(4):447-56. PubMed ID: 17084800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection among drug abusers in the Belgrade area.
    Kilibarda M
    Bull Narc; 1993; 45(1):135-46. PubMed ID: 8305903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
    Collins ED; Horton T; Reinke K; Amass L; Nunes EV
    J Subst Abuse Treat; 2007 Mar; 32(2):167-75. PubMed ID: 17306725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of retention in methadone programs: a signal detection analysis.
    Villafranca SW; McKellar JD; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.